Streetbeat News

Stock Prices

COR

Cencora (NYSE:COR) has outperformed the market over the past 5 years with an average annual return of 23.07%, resulting in a $1000 investment growing to $2,786.77. The article highlights the impact of compounded returns on investment growth.

Portfolio Pulse from Benzinga Insights

September 23, 2024 | 5:30 pm

INTU

Intuit (NASDAQ:INTU) has significantly outperformed the market over the past 5 years, with an average annual return of 19.51%. A $100 investment in Intuit 5 years ago would now be worth $237.93, highlighting the power of compounded returns.

Portfolio Pulse from Benzinga Insights

September 23, 2024 | 5:30 pm

MULN

Mullen Automotive's subsidiary, Bollinger Motors, has produced its first customer-ready B4 electric truck in Michigan, marking a significant milestone. Despite this achievement, Mullen Automotive's shares are trading lower, down 8.5% at $6.11. Bollinger Motors has partnered with Roush Industries for production, leveraging Roush's expertise in e-mobility. The B4 truck is aimed at the commercial fleet market, with a focus on electrification.

Portfolio Pulse from Lekha Gupta

September 23, 2024 | 5:25 pm

ORGS

Orgenesis shares declined following the announcement of a 1-for-10 reverse stock split, which typically reduces the number of shares outstanding and can impact stock price perception.

Portfolio Pulse from Benzinga Newsdesk

September 23, 2024 | 5:22 pm

CIEN

GM

INTC

QCOM

TSLA

VKTX

US stocks opened the week flat as investors await clarity on economic and political fronts. Gold hit record highs, while Tesla surged 4% amid a proposed export ban on Chinese vehicles. Intel rose on Qualcomm takeover rumors, and Ciena received a double upgrade from Citigroup.

Portfolio Pulse from Piero Cingari

September 23, 2024 | 5:20 pm

CVS

CVS Health is experiencing a surge in options activity, with a significant portion of investors adopting a bearish stance. The options activity includes 32 notable trades, with 56% of investors leaning bearish. The stock is currently trading at $57.8, with analysts setting an average price target of $64.0. Recent analyst ratings have been revised downward.

Portfolio Pulse from Benzinga Insights

September 23, 2024 | 5:16 pm

TXN

High-rolling investors are showing a bullish trend in options trading for Texas Instruments (NASDAQ:TXN), with 63% of trades being bullish. The focus is on a price range of $190 to $210. This activity suggests potential insider information and could impact TXN's stock price.

Portfolio Pulse from Benzinga Insights

September 23, 2024 | 5:16 pm

UXIN

Uxin shares rose following the announcement of a year-over-year increase in Q1 sales results.

Portfolio Pulse from Benzinga Newsdesk

September 23, 2024 | 5:14 pm

NVO

Novo Nordisk's CEO, Lars Fruergaard Jørgensen, will face the U.S. Senate Committee on Health, Education, Labor, and Pensions regarding the high prices of Ozempic and Wegovy. The hearing, led by Senator Bernie Sanders, will scrutinize the company's pricing strategy, which is significantly higher in the U.S. compared to other countries. Novo Nordisk is expected to defend its pricing by citing insurance coverage and development costs, despite criticism and potential inclusion in Medicare's negotiated drug prices.

Portfolio Pulse from Vandana Singh

September 23, 2024 | 5:11 pm

TGL

Treasure Global's stock price increased following the announcement of a partnership with Credilab.

Portfolio Pulse from Benzinga Newsdesk

September 23, 2024 | 5:10 pm